DNLI
Price
$14.87
Change
+$0.27 (+1.85%)
Updated
Apr 23 closing price
Capitalization
2.12B
19 days until earnings call
SEER
Price
$2.04
Change
-$0.05 (-2.39%)
Updated
Apr 23 closing price
Capitalization
121.96M
19 days until earnings call
Ad is loading...

DNLI vs SEER

Header iconDNLI vs SEER Comparison
Open Charts DNLI vs SEERBanner chart's image
Denali Therapeutics
Price$14.87
Change+$0.27 (+1.85%)
Volume$1.48M
Capitalization2.12B
Seer
Price$2.04
Change-$0.05 (-2.39%)
Volume$97.13K
Capitalization121.96M
DNLI vs SEER Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. SEER commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Buy and SEER is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (DNLI: $14.87 vs. SEER: $2.04)
Brand notoriety: DNLI and SEER are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 102% vs. SEER: 37%
Market capitalization -- DNLI: $2.12B vs. SEER: $121.96M
DNLI [@Biotechnology] is valued at $2.12B. SEER’s [@Biotechnology] market capitalization is $121.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileSEER’s FA Score has 1 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • SEER’s FA Score: 1 green, 4 red.
According to our system of comparison, SEER is a better buy in the long-term than DNLI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 4 TA indicator(s) are bullish while SEER’s TA Score has 5 bullish TA indicator(s).

  • DNLI’s TA Score: 4 bullish, 4 bearish.
  • SEER’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, DNLI is a better buy in the short-term than SEER.

Price Growth

DNLI (@Biotechnology) experienced а +18.49% price change this week, while SEER (@Biotechnology) price change was +3.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

SEER is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.12B) has a higher market cap than SEER($122M). SEER YTD gains are higher at: -11.688 vs. DNLI (-27.036). SEER has higher annual earnings (EBITDA): -93.93M vs. DNLI (-492.89M). DNLI has more cash in the bank: 832M vs. SEER (236M). SEER has less debt than DNLI: SEER (26M) vs DNLI (48.7M). SEER has higher revenues than DNLI: SEER (13.9M) vs DNLI (0).
DNLISEERDNLI / SEER
Capitalization2.12B122M1,739%
EBITDA-492.89M-93.93M525%
Gain YTD-27.036-11.688231%
P/E RatioN/AN/A-
Revenue013.9M-
Total Cash832M236M353%
Total Debt48.7M26M187%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
39
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLISEER
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
75%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 9 days ago
80%
Bearish Trend 8 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Ad is loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SEER
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JAVTX70.71N/A
N/A
Janus Henderson Venture T
MSGAX10.43N/A
N/A
Meridian Small Cap Growth A
MVSSX26.58N/A
N/A
Victory Integrity Small-Cap Value R6
FSGEX15.04N/A
N/A
Fidelity Series Global ex US Index
RKCIX9.47N/A
N/A
Rockefeller Climate Solutions Instl

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with BEAM. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+1.85%
BEAM - DNLI
59%
Loosely correlated
+3.87%
RCKT - DNLI
57%
Loosely correlated
+2.44%
NTLA - DNLI
56%
Loosely correlated
-2.65%
ARWR - DNLI
56%
Loosely correlated
+5.26%
RGNX - DNLI
56%
Loosely correlated
+13.43%
More

SEER and

Correlation & Price change

A.I.dvisor indicates that over the last year, SEER has been loosely correlated with AXON. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if SEER jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SEER
1D Price
Change %
SEER100%
-2.39%
AXON - SEER
56%
Loosely correlated
+3.82%
ARRY - SEER
47%
Loosely correlated
+0.93%
DNLI - SEER
39%
Loosely correlated
+1.85%
VCYT - SEER
35%
Loosely correlated
+1.08%
PMVP - SEER
34%
Loosely correlated
-0.93%
More